Parkinson’s Small Molecule Compound Kit-1 KBPD-1
Name：Parkinson’s Small Molecule Compound Kit-1
Specification：9*1mL(10mM) ; 9*2mg ; 9*5mg
Storage conditions：Store at -20℃
Shipping conditions： Freeze transportation
Product Introduction
| CAS number | Product number | Product name | Molecular formula | molecular weight | Corresponding target | Product Description |
| 34157-83-0 | IC0220 | Celastrol; triptolide | C 29 H 38 O 4 | 450.61 | Proteasome | It is a proteasome inhibitor that potently and preferentially inhibits the chymotrypsin-like activity of the 20S proteasome. |
| 59-92-7 | ID0360 | L-DOPA; Levodopa | C9H11NO4 | 197.19 | Dopamine Receptor | It is one of the precursors for the synthesis of norepinephrine and dopamine in humans and animals. It is a precursor of the neurotransmitter dopamine with catechin light base and can be used in the research of drug treatment of Parkinson's disease. |
| 23007-85-4 | I19290 | MPTP Hydrochloride; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride | C12H16ClN | 209.72 | Dopamine Receptor | It is a dopaminergic neurotoxin that can selectively destroy dopaminergic neurons in animal models of Parkinson's disease. |
| 38821-49-7 | IC1300 | Carbidopa Monohydrate; carbidopa monohydrate | C10H14N2O4·H2O | 244.24 | Decarboxylase | It is a peripheral decarboxylase inhibitor and selective aryl hydrocarbon receptor (AhR) modulator that can be used in the study of Parkinson's disease. |
| 155270-99-8 | II1500 | Istradefylline; istradefylline | C20H24N4O4 | 384.43 | Adenosine Receptor | Is a potent, selective adenosine A2A receptor antagonist. |
| 104054-27-5 | IA4200 | Atipamezole; Atipamezole | C14H16N2 | 212.29 | Adrenergic Receptor | Atipamezole is an alpha2-adrenergic receptor antagonist. |
| 14919-77-8 | IB2520 | Benserazide Hydrochloride; benserazide hydrochloride | C10H15N3O5·HCl | 293.7 | aromatic L-amino acid decarboxylase (AADC) | It is an inhibitor of aromatic L-amino acid decarboxylase (AADC) and is commonly used in research related to Parkinson's disease. |
| 161735-79-1 | IR1080 | Rasagiline Mesylate; rasagiline mesylate | C 12 H 13 N CH 4 O 3 S | 267.34 | Monoamine Oxidase | It is a new type of MAO-B inhibitor that can be used in research related to sudden Parkinson's disease. |
| 133865-89-1 | IS2400 | Safinamide;Safinamide | C 17 H 19 FN 2 O 2 | 302.34 | Monoamine Oxidase | It is a reversible MAO-B inhibitor with neuroprotective effects and can be used in the research of Parkinson's disease, ischemic stroke and other diseases . |
This set selects several compounds commonly used in Parkinson's disease-related research to facilitate customers' preliminary screening and other operations. Customers can also flexibly customize exclusive Kits according to their own needs.
| ||||||
Things to note
Considerations
1. This product is for scientific research use only. Do not use it for medicine, clinical diagnosis or treatment, food and cosmetics, etc. Do not store in ordinary residential areas.
2. For your safety and health, please wear a lab coat, disposable gloves and a mask.
3. The experimental results can be affected by many factors. The relevant processing is limited to the product itself and does not involve other compensation.
sales